REPROCELL Unveils Cutting-Edge Neoantigen Detection Service to Propel Precision Cancer Immunotherapy
20 August 2025
REPROCELL launches NeoSight, a neoantigen detection service for personalized cancer immunotherapy, offering high-confidence data and applications like cancer vaccines and biomarker discovery.
REPROCELL and BioBridge Global sign Memorandum of Understanding to accelerate global manufacturing services using clinical iPSCs
04 October 2022
REPROCELL and Texas-based BioBridge Global have signed a Memorandum of Understanding to enhance their strategic collaborative relationship. Find out more.
PRESS RELEASE: Axion BioSystems make REPROCELL a product distributor
28 August 2019
Axion BioSystems has announced REPROCELL as the new distributor of its Maestro products in Japan. Read the official Press Release at reprocell.com
Appointment of New Distributor in China
01 February 2019
The REPROCELL group has signed non-exclusive distributorship agreement with RUITAI Biotechnology (Shanghai) Ltd to distribute REPROCELL’s group products in China.